Literature DB >> 12954175

Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats.

Feng Wang1, Xinguo Jiang, Wei Lu.   

Abstract

The aim of this paper was to investigate the levels of methotrexate (MTX) in blood and the cerebrospinal fluid (CSF) in rats to find out whether there is any direct drug transport from nasal cavity to CSF following intranasal administration. Methotrexate was administered to male Sprague-Dawley rats either intranasally or intravenously. Drug concentrations were determined from CSF and plasma samples collected from the cisterna magna and caudal vein, respectively. To collect CSF sample continuously, blank artificial CSF was infused into the lateral ventricle. The plasma levels achieved following intranasal administration were significantly lower than those after intravenous administration (P<0.01) were, while CSF concentrations achieved after intranasal administration were significantly higher than those after intravenous administration (P<0.01). The ratio of the AUC(CSF) value between the intranasal route and the intravenous injection was 13.76, whereas the absolute bioavailability was only 6.3%, the drug targeting index (DTI) of nasal route was 21.7. In conclusion, these results showed that the antineoplastic MTX must be directly transported from the nasal cavity into the CSF in rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954175     DOI: 10.1016/s0378-5173(03)00341-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  18 in total

Review 1.  A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option.

Authors:  Asa Peterson; Amy Bansal; Florence Hofman; Thomas C Chen; Gabriel Zada
Journal:  J Neurooncol       Date:  2014-01-08       Impact factor: 4.130

Review 2.  Pharmacokinetic considerations in the treatment of CNS tumours.

Authors:  Susannah Motl; Yanli Zhuang; Christopher M Waters; Clinton F Stewart
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  Breast cancer: insights in disease and influence of drug methotrexate.

Authors:  Vítor Yang; Maria João Gouveia; Joana Santos; Beate Koksch; Irina Amorim; Fátima Gärtner; Nuno Vale
Journal:  RSC Med Chem       Date:  2020-05-28

4.  Donepezil HCl Liposomes: Development, Characterization, Cytotoxicity, and Pharmacokinetic Study.

Authors:  Amarjitsing Rajput; Shital Butani
Journal:  AAPS PharmSciTech       Date:  2022-02-11       Impact factor: 3.246

Review 5.  Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy.

Authors:  Dannielle H Upton; Caitlin Ung; Sandra M George; Maria Tsoli; Maria Kavallaris; David S Ziegler
Journal:  Theranostics       Date:  2022-06-06       Impact factor: 11.600

6.  New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.

Authors:  Rintaro Hashizume; Tomoko Ozawa; Sergei M Gryaznov; Andrew W Bollen; Kathleen R Lamborn; William H Frey; Dennis F Deen
Journal:  Neuro Oncol       Date:  2008-02-20       Impact factor: 12.300

Review 7.  Novel therapeutic delivery approaches in development for pediatric gliomas.

Authors:  Katherine E Warren
Journal:  CNS Oncol       Date:  2013-09

8.  Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20).

Authors:  Gloriane W Schnabolk; Geri L Youngblood; Douglas H Sweet
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-14

9.  Effect of polysorbate 80 on the intranasal absorption and brain distribution of tetramethylpyrazine phosphate in rats.

Authors:  Mingyue Gao; Dan Mei; Yingnan Huo; Shirui Mao
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

Review 10.  Blood brain barrier: a challenge for effectual therapy of brain tumors.

Authors:  Arijit Bhowmik; Rajni Khan; Mrinal Kanti Ghosh
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.